Taught by Matthew Gasda
Mar 12, Mar 19, Mar 26, April 2 (Thursdays)
1:00 pm to 3:00 pm
Manhattan Center for Theatre Research*
For actors, but also useful to directors, this four week class will work on scenes from Matt's oeuvre, focusing on, but not limited to Dimes Square, Zoomers, Morning Journal, Quartet, Minotaur, and Ardor.
As we explore these plays, we will also discuss the broader themes and ideas that they explore, including identity, relationships, sexuality and power dynamics, and mortality. We will engage in in-depth discussions about the text, exploring how conceptual understandings of the texts can find objective correlates in performance. Actors will also explore acting in a "chamber" environment, honing in on the kinds of acting techniques that really sing in smaller, intimate spaces.
*Please note that we are at a new location: 13 West 17th Street, New York, NY 10011
——————
Matthew Gasda a theatre director and the author of numerous plays, novels, poems and essays. He is a co-founder of the BCTR.
Taught by Matthew Gasda
Mar 12, Mar 19, Mar 26, April 2 (Thursdays)
1:00 pm to 3:00 pm
Manhattan Center for Theatre Research*
For actors, but also useful to directors, this four week class will work on scenes from Matt's oeuvre, focusing on, but not limited to Dimes Square, Zoomers, Morning Journal, Quartet, Minotaur, and Ardor.
As we explore these plays, we will also discuss the broader themes and ideas that they explore, including identity, relationships, sexuality and power dynamics, and mortality. We will engage in in-depth discussions about the text, exploring how conceptual understandings of the texts can find objective correlates in performance. Actors will also explore acting in a "chamber" environment, honing in on the kinds of acting techniques that really sing in smaller, intimate spaces.
*Please note that we are at a new location: 13 West 17th Street, New York, NY 10011
——————
Matthew Gasda a theatre director and the author of numerous plays, novels, poems and essays. He is a co-founder of the BCTR.